2026

Evonik invests US$100 million to upgrade its U.S. drug substance contract manufacturing site

News Medical July 14, 2026 0Comment

Evonik is making a significant investment to strengthen manufacturing capabilities at its Lafayette (Tippecanoe), Indiana facility.

AI-powered DANDELION identifies overlooked genes linked to asthma

Machine learning creates a color wheel for complex odors

Cryo-EM provides real-time glimpse of cellular machinery reading DNA inside living organisms

Scientists uncover safer way to tame cancer cell senescence